Cryptococcosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 40 pages | ID: C6F9D60E7992EN
VPAResearch

Abstracts

Cryptococcosis Drug pipeline report- 2020 is an annual R&D review of Cryptococcosis pipeline candidates. The report presents the current status of all major Cryptococcosis therapeutic compounds. Detailed insights into Cryptococcosis pipeline development, current status, companies, drug profiles and Cryptococcosis preclinical and clinical trials are included.

2020 Cryptococcosis Pipeline Market Insights
Cryptococcosis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Cryptococcosis therapies, pipeline by phase and others are included.

Cryptococcosis pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Cryptococcosis Therapeutic Drug candidates
Both active and inactive Cryptococcosis pipeline drug candidates are included in the report

Cryptococcosis Clinical Trials and preclinical Studies
Cryptococcosis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Cryptococcosis pipeline market developments
Cryptococcosis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Cryptococcosis pipeline companies in active development
The report analyzes Cryptococcosis pipeline of the below companies-

Amplyx Pharmaceuticals Inc, Amtixbio Co Ltd, Basilea Pharmaceutica Ltd, Collaborations Pharmaceuticals Inc , Matinas BioPharma, Novabiotics Ltd, Pulmocide Ltd, Viamet Pharmaceuticals Inc, Visterra Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
9 Companies investing in Cryptococcosis pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Cryptococcosis pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. CRYPTOCOCCOSIS PIPELINE MARKET INSIGHTS, 2020

1.1 Cryptococcosis Disease Overview
1.2 Cryptococcosis Drug Pipeline Snapshot, 2020
  1.2.1 Cryptococcosis Pipeline Drugs by Phase
  1.2.2 Cryptococcosis Pipeline Drugs by Company
  1.2.3 Cryptococcosis Pipeline Drugs by Mechanism of Action
  1.2.4 Cryptococcosis Pipeline Drugs by Route of Administration

2. CRYPTOCOCCOSIS COMPANY WISE PIPELINE DETAILS

Amplyx Pharmaceuticals Inc Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Amtixbio Co Ltd Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Basilea Pharmaceutica Ltd Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Collaborations Pharmaceuticals Inc Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Matinas BioPharma Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novabiotics Ltd Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pulmocide Ltd Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Viamet Pharmaceuticals Inc Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Visterra Inc Cryptococcosis Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. CRYPTOCOCCOSIS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. CRYPTOCOCCOSIS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts